Figure 1.
Stem cell phenotype of Csnk1a1fl/+, Egr1–/+ and Csnk1a1fl/+Egr1–/+ mice. (A) White blood cell counts recorded at 4, 7, 11, 16, and 20 weeks after transplant. (B) Frequency of CD11b+ myeloid cells of viable blood cells at 20 weeks after transplant (euthanize). (C) Frequency of CD45.2+ cells in bone marrow LK (Lin– and ckit+) and LSK (Lin– Sca1+ ckit+) in bone marrow at 20 weeks after transplant (euthanize). (D) Frequency of MPP (CD48+CD150–LSK), ST-HSC (CD48-CD150- LSK), and long-term hematopoietic stem cells (CD48-CD150+ LSK) in CD45.2+ LSK cells in the bone marrow at harvest. (E) Colony forming potential of sorted LSK cells from Mx1Cre, Csnk1a1fl/+, Egr1–/+, and Csnk1a1fl/+Egr1–/+ mice plated in methylcellulose at first and second plating. (F) Gene set enrichment analysis of Hallmark pathways on RNA sequencing data of sorted LSK; columns signify enriched pathways of contrast Egr1–/+ vs Mx1Cre+, Csnk1a1fl/+ vs Mx1Cre+, and Csnk1a1fl/+Egr1–/+ vs Mx1Cre+. (G) Characterization of cell type proportions of sorted LSK based on Cibersort tumor profiling. (H) Ridgeline plot comparing gene distribution of G2M- and S-phase genes based on Cibersort tumor profiling. (I) Intracellular Ki67 and 7-AAD staining to discriminate the cell cycle phases G0, G1, S-G2-M) within Mx1Cre, Csnk1a1fl/+, Egr1–/+ and Csnk1a1fl/+Egr1–/+ HoxB8-Flt3 cells. (J) Flow cytometric analysis of the competitive coculture assay of HOXB8 cells derived from Mx1Cre (GFP+) against HOXB8 cells derived from Csnk1a1fl/+, Egr1–/+, and Csnk1a1fl/+Egr1–/+ HoxB8-Flt3 cells (GFP–) over 6 days. Data represent the mean ± standard error of the mean. Statistical test was performed by 1-way analysis of variance with Dunnet post hoc test to compare each genotype to control (Mx1Cre). Only significant results are marked and all other comparisons were nonsignificant. HGB, hemoglobin; IFN, interferon; PBS, phosphate-buffered saline; WBC, white blood cell.

Stem cell phenotype of Csnk1a1fl/+, Egr1–/+ and Csnk1a1fl/+Egr1–/+ mice. (A) White blood cell counts recorded at 4, 7, 11, 16, and 20 weeks after transplant. (B) Frequency of CD11b+ myeloid cells of viable blood cells at 20 weeks after transplant (euthanize). (C) Frequency of CD45.2+ cells in bone marrow LK (Lin and ckit+) and LSK (Lin Sca1+ ckit+) in bone marrow at 20 weeks after transplant (euthanize). (D) Frequency of MPP (CD48+CD150LSK), ST-HSC (CD48-CD150- LSK), and long-term hematopoietic stem cells (CD48-CD150+ LSK) in CD45.2+ LSK cells in the bone marrow at harvest. (E) Colony forming potential of sorted LSK cells from Mx1Cre, Csnk1a1fl/+, Egr1–/+, and Csnk1a1fl/+Egr1–/+ mice plated in methylcellulose at first and second plating. (F) Gene set enrichment analysis of Hallmark pathways on RNA sequencing data of sorted LSK; columns signify enriched pathways of contrast Egr1–/+ vs Mx1Cre+, Csnk1a1fl/+ vs Mx1Cre+, and Csnk1a1fl/+Egr1–/+ vs Mx1Cre+. (G) Characterization of cell type proportions of sorted LSK based on Cibersort tumor profiling. (H) Ridgeline plot comparing gene distribution of G2M- and S-phase genes based on Cibersort tumor profiling. (I) Intracellular Ki67 and 7-AAD staining to discriminate the cell cycle phases G0, G1, S-G2-M) within Mx1Cre, Csnk1a1fl/+, Egr1–/+ and Csnk1a1fl/+Egr1–/+ HoxB8-Flt3 cells. (J) Flow cytometric analysis of the competitive coculture assay of HOXB8 cells derived from Mx1Cre (GFP+) against HOXB8 cells derived from Csnk1a1fl/+, Egr1–/+, and Csnk1a1fl/+Egr1–/+ HoxB8-Flt3 cells (GFP) over 6 days. Data represent the mean ± standard error of the mean. Statistical test was performed by 1-way analysis of variance with Dunnet post hoc test to compare each genotype to control (Mx1Cre). Only significant results are marked and all other comparisons were nonsignificant. HGB, hemoglobin; IFN, interferon; PBS, phosphate-buffered saline; WBC, white blood cell.

Close Modal

or Create an Account

Close Modal
Close Modal